Hi there! Welcome.

Currently, I am a Director of Real-world Biostatistics at GSK, where I design and analyze real-world data studies in oncology, applying novel causal inference methods for robust evidence generation.

My methodological research addresses biases that arise when combining trials and real-world data. I previously led a research team at J&J to develop novel statistical methods to quantify and mitigate biases due to endpoint measurement differences when conducting external control arm analyses. See here to learn more about this research.

I earned my PhD in Biostatistics at the Johns Hopkins Bloomberg School of Public Health where I was advised by Dr. Elizabeth Stuart. My dissertation research focused on statistical methods for generalizing findings from randomized trials to a target population, and transporting measurement error correction from validation studies to intervention trials. My applied public health interests also include oncology, mental health, and LGBTQ+ health.

Experience

Education

Johns Hopkins University | Baltimore, MD
BA in Public Health Studies | August 2011 - May 2015